Showing results (731-740 of 859) with videos related to

Sort By:
Pageof 86
Acta Neurochirurgica|January 17, 2025
In vivo 9.4 Tesla MRI of a patient with drug-resistant epilepsy: Technical reportRick H G J van Lanen, Daniel Uher, Desmond H Y Tse, et al.
Brain and Behavior|October 1, 2016
Reliable measurements of brain atrophy in individual patients with multiple sclerosisDirk Smeets, Annemie Ribbens, Diana M Sima, et al.
Journal of Psychopharmacology (Oxford, England)|November 22, 2013
Genetic differences in cytochrome P450 enzymes and antidepressant treatment responseKaren Hodgson, Katherine Tansey, Mojca Zvezdana Dernovsek, et al.
The Journal of Rheumatology|April 3, 2020
Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics DatabasesMatthew L Thomas, Gavin Shaddick, Rachel Charlton, et al.
Psychological Medicine|August 25, 2022
Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 reportMehri Sajjadian, Rudolf Uher, Keith Ho, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|March 31, 2026
Emerging conduction pathways in semiconducting bismuth-antimony alloysShriya Sinha, Zecheng You, Shane Smolenski, et al.
Nature Communications|May 6, 2026
Minimal twin structures enabling extraordinary thermoelectric power factor of n-type Bi2Te3 thin filmsHaoran Ge, Rui Cheng, Wei Liu, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 2, 2015
Transcriptomics and the mechanisms of antidepressant efficacyKaren Hodgson, Katherine E Tansey, Timothy R Powell, et al.
Journal of Affective Disorders|July 9, 2010
Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEPRobert Keers, Rudolf Uher, Bhanu Gupta, et al.
Journal of Psychopharmacology (Oxford, England)|May 14, 2015
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelinesAnthony Cleare, C M Pariante, A H Young, et al.
Pageof 86